The Regeneration and Sustainability Award honors trailblazing work by Treehouse California Almonds and The Almond Project partners to advance sustainable farming methods in California’s almond industry. EARLIMART, Calif., March 14, 2023 /PRNewswire/ — Treehouse California Almonds, a…
Month: March 2023
LUXEMBOURG, March 14, 2023 /PRNewswire/ — Globant S.A. (NYSE: GLOB), a digitally native technology services company (the “Company”), announces that its Annual General Meeting of Shareholders and an Extraordinary General Meeting of Shareholders (collectively, the “General Meetings”) are…
WOBURN, Mass., March 14, 2023 /PRNewswire/ — Today Monotype® announced its acquisition of five premium typeface families from the Milieu Grotesque catalogue and Paulo Goode’s current type catalogue. First established in 2010 by graphic designers Timo Gaessner and Alexander Colby, Milieu…
Business Combination to deliver approximately $36 million of gross proceeds YS Biopharma expects to close the Business Combination on March 16, 2023 YS Biopharma Ordinary Shares and YS Biopharma Warrants expected to begin trading on the Nasdaq on March 17, 2023 under the symbols “YS” and…
BALTIMORE and PALO ALTO, Calif., March 14, 2023 /PRNewswire/ — Delfi Diagnostics, Inc., a pioneering developer of a new class of high-performance, accessible liquid biopsy tests for early cancer detection and monitoring, will present multiple oral and poster presentations showcasing the…
NORWOOD, Mass., March 14, 2023 /PRNewswire/ — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a precision oncology company, today announced that an abstract highlighting pre-clinical data for CRB-601, its avβ8 blocking antibody, has been accepted for…
SOUTH SAN FRANCISCO, Calif., March 14, 2023 /PRNewswire/ — IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced publication of abstracts at the 2023 Annual…
BOSTON, March 14, 2023 /PRNewswire/ — HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule allosteric therapies targeting regulatory sites on proteins referred to as “natural hotspots,” today announced it will present two…
PARSIPPANY, N.J., March 14, 2023 /PRNewswire/ — PBF Energy Inc. (NYSE: PBF) announced that Georganne Hodges and Damian W. Wilmot have been appointed as independent directors effective as of March 15, 2023. Thomas J. Nimbley, Chairman of the Board and Chief Executive Officer, commented,…
– Company plans to highlight preclinical proof-of-concept data for EO-3021 in an oral presentation at the New Drugs on the Horizon special session NEW YORK, March 14, 2023 /PRNewswire/ — Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and…